Holen Sie sich die Stockscreener-App
96.24
1.36%
1.29
Handel nachbörslich:
96.48
0.24
+0.25%
Boston Scientific Corp Aktie (BSX) Neueste Nachrichten
What Makes Boston Scientific Corporation (BSX) an Investment Choice? - Yahoo Finance
Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025? - Yahoo Finance
What Fibonacci levels say about Boston Scientific Corporation reboundMarket Activity Summary & Weekly Watchlist for Consistent Profits - newser.com
OFI Invest Asset Management Has $1.38 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
What You Need To Know Ahead of Boston Scientific's Earnings Release - MSN
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific (BSX) Stock Moves -1.92%: What You Should Know - Yahoo Finance
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Is Boston Scientific Corporation stock a safe buy pre earningsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Real time alert setup for Boston Scientific Corporation performance2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
How to forecast Boston Scientific Corporation trends using time series2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Shell Asset Management Co. Increases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Evercore ISI Revises Boston Scientific (BSX) Price Target to $11 - GuruFocus
Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Ma - GuruFocus
Boston Scientific (BSX): Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation - simplywall.st
What You Need To Know Ahead Of Boston Scientific's Earnings Release - Barchart.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Using data tools to time your Boston Scientific Corporation exitMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Cullinan Associates Inc. Sells 13,300 Shares of Boston Scientific Corporation $BSX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 5,188 Shares of Boston Scientific Corporation $BSX - MarketBeat
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $125 to $136 - 富途牛牛
QRG Capital Management Inc. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific Corporation stock remains on watchlists2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Is Boston Scientific’s Innovation Push in Endoscopy at MEDevice Boston a Sign of R&D Leadership (BSX)? - Yahoo Finance
Penobscot Investment Management Company Inc. Buys 10,177 Shares of Boston Scientific Corporation $BSX - MarketBeat
Jackson Wealth Management LLC Has $4.91 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Truist Financial Corp Sells 18,116 Shares of Boston Scientific Corporation $BSX - MarketBeat
Sava Infond d.o.o. Has $5.79 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
How Are Analysts Weighing Boston Scientific’s (BSX) Innovation Pipeline Against Market Execution Strategies? - simplywall.st
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) - Yahoo Finance
Boston Scientific stock rating reiterated at Overweight by Piper Sandler - Investing.com
FY2027 EPS Estimate for Boston Scientific Boosted by Analyst - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - sharewise.com
Boston Scientific stock rating downgraded to Hold by Erste Group - Investing.com
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT - Insider Monkey
Consolidated Portfolio Review Corp Acquires Shares of 3,136 Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock benefits from digital adoptionEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Yahoo Finance
Oppenheimer Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
Leerink Partners Reaffirms Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
27,070 Shares in Boston Scientific Corporation $BSX Bought by Lecap Asset Management Ltd. - MarketBeat
Boston Scientific aims for market leadership in electrophysiology - Yahoo Finance
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific (NYSE:BSX) Price Target Raised to $129.00 at Truist Financial - Defense World
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
Oppenheimer reiterates Outperform rating on Boston Scientific stock By Investing.com - Investing.com Nigeria
Boston Scientific (BSX) Analyst Rating Update: Canaccord Genuity Raises Price Target | BSX Stock News - GuruFocus
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
What consensus target says about Boston Scientific Corporation stock2025 Biggest Moves & Verified Entry Point Detection - newser.com
Baird Raises Price Target for Boston Scientific (BSX) to $128.00 | BSX Stock News - GuruFocus
Boston Scientific stock outlook positive as TD Cowen reiterates buy rating - Investing.com
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - The Manila Times
Robert W. Baird Raises Boston Scientific (NYSE:BSX) Price Target to $128.00 - MarketBeat
Boston Scientific stock rating reiterated at Buy by Stifel on growth outlook - Investing.com
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Benzinga
$88M Deal: Elutia Sells BioEnvelope to Boston Scientific, Targets $1.5B Breast Reconstruction Market - Stock Titan
Vaginal Mesh Lawsuit Settlements | October 2025 Updates - Lawsuit Information Center
Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday - inkl
Boston Scientific stock gets Outperform rating from Bernstein on growth outlook - Investing.com
1.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):